Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - Consort Medical plc

13 Jan 2020 11:09

RNS Number : 6067Z
Consort Medical PLC
13 January 2020
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Paul Hayes

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Consort Medical plc

(d) Status of person making the disclosure:

Person acting in concert with Consort Medical plc

(e) Date dealing undertaken:

7 January 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

12,467

0.025

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

12,467

0.025

Nil

Nil

 

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

10p ordinary shares

Details, including nature of the rights concerned and relevant percentages:

 

Performance Share Plan 2015

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

20 June 2017

Option

29,990

Nil

20 June 2020 - 19 June 2027

19 July 2018

Option

25,952

Nil

20 June 2023 - 18 July 2028

23 August 2019

Option

67,150

Nil

24 August 2024 - 22 August 2029

 

Deferred Bonus Plan 2010

Date of grant

 

Type of award

Number of shares under option

Exercise price

Exercise period

19 June 2018

Option

8,629

Nil

19 June 2021 - 29 July 2021

24 July 2019

Option

9,966

Nil

24 July 2022 - 2 September 2022

 

Sharesave

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

24 July 2019

Option

2,325

£7.74

1 September 2022 - 28 February 2023

 

 

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

 

(a) Purchases and sales

 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary shares

Purchase

 

15

£10.299

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

 

Nature of dealing

 

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

 

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

 

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

 

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

 

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

13 January 2020

Contact name:

Andrew Jackson, Company Secretary

Telephone number:

+44 (0) 1442 867920

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DCCKKNBKDBKDPDD
Date   Source Headline
18th Jul 201410:21 amRNSDirector/PDMR Shareholding
16th Jul 20147:00 amRNSDirector/PDMR Shareholding
14th Jul 20147:00 amRNSDirectorate Change
1st Jul 20143:46 pmRNSTotal Voting Rights
26th Jun 201410:37 amRNSHolding(s) in Company
24th Jun 20144:15 pmRNSHolding(s) in Company
23rd Jun 20144:28 pmRNSDirector/PDMR Shareholding
23rd Jun 20144:23 pmRNSDirector/PDMR Shareholding
19th Jun 20142:42 pmRNSDirector/PDMR Shareholding
17th Jun 20147:00 amRNSFinal results for the year ended 30 April 2014
4th Jun 20147:00 amRNSDirector Declaration
2nd Jun 20143:16 pmRNSBlocklisting Interim Review
22nd May 20147:00 amRNSChange of Adviser
16th May 201410:39 amRNSHolding(s) in Company
13th May 20147:00 amRNSKing Systems Milestone Payment
14th Apr 20144:58 pmRNSBlocklisting Interim Review
3rd Apr 201411:15 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSDirector Declaration
19th Mar 20147:00 amRNSInterim Management Statement
3rd Mar 20149:00 amRNSTotal Voting Rights
6th Feb 201410:24 amRNSHolding(s) in Company
5th Feb 20142:45 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSFDA Approval of Development Programme
28th Jan 20149:43 amRNSHolding(s) in Company
3rd Jan 20149:15 amRNSTotal Voting Rights
31st Dec 20139:34 amRNSHolding(s) in Company
4th Dec 20137:00 amRNSInterim results for the six months to 31/10/13
2nd Dec 20134:15 pmRNSBlocklisting Interim Review
2nd Dec 20134:14 pmRNSTotal Voting Rights
28th Nov 20137:00 amRNSBespak Supply Contract Award
20th Nov 20131:37 pmRNSJefferies 2013 Global Healthcare Conference
15th Nov 20131:54 pmRNSDirector Declaration
4th Nov 20133:37 pmRNSHolding(s) in Company
1st Nov 20137:00 amRNSTotal Voting Rights
31st Oct 201312:21 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
14th Oct 20134:09 pmRNSBlocklisting Interim Review
14th Oct 20133:58 pmRNSHolding(s) in Company
11th Oct 201312:08 pmRNSHolding(s) in Company
10th Oct 20133:32 pmRNSHolding(s) in Company
30th Sep 20133:26 pmRNSTotal Voting Rights
27th Sep 201310:17 amRNSDirector/PDMR Shareholding
6th Sep 20131:51 pmRNSHolding(s) in Company
5th Sep 20131:39 pmRNSDirector/PDMR Shareholding
3rd Sep 201310:15 amRNSResult of AGM
2nd Sep 20137:00 amRNSInterim Management Statement
26th Jul 20132:52 pmRNSPosting of Annual Report and Notice of AGM
24th Jul 20132:43 pmRNSDirector/PDMR Shareholding
22nd Jul 20137:00 amRNSBespak development contract award
27th Jun 201312:27 pmRNSBlocklisting
25th Jun 20134:11 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.